KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastoma

Nina Weichert‐Leahey(Dana-Farber Cancer Institute), A. Thomas Look(Dana-Farber Cancer Institute)
bioRxiv (Cold Spring Harbor Laboratory)
July 2, 2025
Cited by 1


Related Papers